Tamoxifen 20 mg once-daily reduces the risk of breast cancer recurrence after ductal carcinoma in situ (DCIS), but its use is limited by adverse effects. Lower doses may be effective, but benefit ...

Cost-saving analysis of neoadjuvant versus adjuvant immunotherapy in clinical stage III melanoma: A real-world Brazilian perspective. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting ...

National security, unlocked. Each Thursday, host Mary Louise Kelly and a team of NPR correspondents discuss the biggest national security news of the week. With decades of reporting from battlefields ...

The unprecedented expansion of approved oncology therapies has prolonged survival and transformed the prognosis for many patients diagnosed with cancer. However, cancer treatments may be associated ...

Waterdrop Inc. ('Waterdrop', the 'Company' or 'we') (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare services with a positive social impact, today announced its ...

Breast cancer is a biologically heterogeneous disease in which genomic complexity, dynamic tumor evolution, and variable therapeutic response continue to ...

T-cell large granular lymphocyte leukaemia (T-LGLL) is a chronic lymphoproliferative disorder often associated with pure red ...

Business Wire India Approval introduces Pulsed Field Ablation technology to India. The VARIPULSE™ Platform is the first ...

Worldwide Healthcare Trust PLC - Annual Financial Report PR Newswire LONDON, United Kingdom, June 05 4 June 2026 Worldwide ...